GPBAR1 and ovarian serous adenocarcinoma: A recent study has reported that G-protein-coupled bile acid receptor-1 (GPBAR1) is overexpressed in patients with serous ovarian cancer (SOC) and is significantly associated with the poor prognosis of OC (35).